Substantial doubt about the company's ability to continue as a going concern.
“Without additional funding, there is substantial doubt about the Company's ability to continue as a going concern for the twelve months from the date of these financial statements.”View the 10-Q filed Aug 17, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Raw chart and full-history price indicators begin at the captured split on Nov 4, 2024; bars on opposite sides are not compared.
Regen Biopharma entered agreements with Coventry Enterprises: a $125,000 10% unsecured promissory note with $12,500 retained, repayable in 8 equal monthly payments of 17,187.50 Dollars, plus a 36-month equity line up to $10,000,000.
Useful current figures from the complete screener profile.
* Q4 derived as the full year minus Q1 to Q3.
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Illustrative technical + ownership context — a signal mix, not investment advice.
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
RGBP
this stock
Regen BioPharma Inc
|
$335,055 | -97.3% | +0.8% | — | 0.0% |
|
VRTX
Vertex Pharmaceuticals Inc
|
$138.71B | +20.7% | +46.2% | 35.2 | 1.7% |
|
MRNA
Moderna, Inc.
|
$96.40B | +762.0% | +4.3% | — | 8.2% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$93.82B | +17.2% | +20.8% | 20.1 | 2.1% |
|
CSLLY
Csl Ltd
|
$66.72B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
Regen Biopharma entered agreements with Coventry Enterprises: a $125,000 10% unsecured promissory note with $12,500 retained, repayable in 8 equal monthly payments of 17,187.50 Dollars, plus a 36-month equity line up to $10,000,000.
ViewRaw-price comparisons begin at the captured split on Nov 4, 2024; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| RGBP | +100.0% | +100.0% | -33.3% | +100.0% | -97.3% |
| SPY | -2.7% | -5.6% | -0.5% | -2.7% | +7.8% |
| vs SPY | +102.7% | +105.6% | -32.9% | +102.7% | -105.1% |
